JP2019530673A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019530673A5 JP2019530673A5 JP2019513929A JP2019513929A JP2019530673A5 JP 2019530673 A5 JP2019530673 A5 JP 2019530673A5 JP 2019513929 A JP2019513929 A JP 2019513929A JP 2019513929 A JP2019513929 A JP 2019513929A JP 2019530673 A5 JP2019530673 A5 JP 2019530673A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- platelet cells
- composition
- therapeutic agent
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023061666A JP7497087B2 (ja) | 2016-09-13 | 2023-04-05 | 治療剤送達のための血小板組成物及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662393839P | 2016-09-13 | 2016-09-13 | |
| US62/393,839 | 2016-09-13 | ||
| PCT/US2017/051376 WO2018053010A1 (en) | 2016-09-13 | 2017-09-13 | Platelet compositions and methods for the delivery of therapeutic agents |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023061666A Division JP7497087B2 (ja) | 2016-09-13 | 2023-04-05 | 治療剤送達のための血小板組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019530673A JP2019530673A (ja) | 2019-10-24 |
| JP2019530673A5 true JP2019530673A5 (enExample) | 2020-10-22 |
| JP7262774B2 JP7262774B2 (ja) | 2023-04-24 |
Family
ID=61620161
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019513929A Active JP7262774B2 (ja) | 2016-09-13 | 2017-09-13 | 治療剤送達のための血小板組成物及び方法 |
| JP2023061666A Active JP7497087B2 (ja) | 2016-09-13 | 2023-04-05 | 治療剤送達のための血小板組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023061666A Active JP7497087B2 (ja) | 2016-09-13 | 2023-04-05 | 治療剤送達のための血小板組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11730765B2 (enExample) |
| EP (1) | EP3512554B1 (enExample) |
| JP (2) | JP7262774B2 (enExample) |
| KR (2) | KR20230109771A (enExample) |
| CN (1) | CN109890420B (enExample) |
| AU (1) | AU2017327360A1 (enExample) |
| CA (1) | CA3036693A1 (enExample) |
| WO (1) | WO2018053010A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190388407A1 (en) | 2017-02-12 | 2019-12-26 | Aiviva Biopharma, Inc. | Multikinase inhibitors of vegf and tfg beta and uses thereof |
| US11073462B2 (en) | 2017-12-06 | 2021-07-27 | Lightintegra Technology Inc. | Non-activated platelet transfusion methods for enhancement of patient treatment outcomes |
| JP2021509812A (ja) | 2018-01-05 | 2021-04-08 | プレートレット バイオジェネシス， インコーポレイテッド | 巨核球を産生するための組成物および方法 |
| JP7551110B2 (ja) * | 2018-04-06 | 2024-09-17 | ノース カロライナ ステート ユニバーシティ | 癌免疫療法のためのチェックポイント阻害剤の細胞集団を介した送達 |
| EP3813853A4 (en) | 2018-06-29 | 2022-04-06 | Platelet Biogenesis, Inc. | DELIVERY COMPOSITIONS AND METHODS OF USE |
| CN112839652A (zh) | 2018-08-15 | 2021-05-25 | 艾葳生物科技有限公司 | VEGF和TGFβ的多激酶抑制剂及其用途 |
| CN113164523A (zh) * | 2018-10-10 | 2021-07-23 | 北卡罗莱纳州立大学 | 呈现pd-l1的血小板逆转新发1型糖尿病 |
| WO2022006011A1 (en) * | 2020-07-01 | 2022-01-06 | Cello Therapeutics, Inc. | Platelet membrane coated nanoparticles and uses thereof |
| CN112826941A (zh) * | 2020-08-14 | 2021-05-25 | 南京邮电大学 | 一种用于递送蛋白药物的磁性血小板复合物的制备方法 |
| CN112891317A (zh) * | 2021-02-05 | 2021-06-04 | 东南大学 | 一种血小板载药系统的制备方法 |
| WO2024102818A1 (en) * | 2022-11-09 | 2024-05-16 | Wisconsin Alumni Research Foundation | Combination tumor therapy with thrombosis initiation and platelet recruitment |
| CN116159149B (zh) * | 2023-02-27 | 2024-11-15 | 上海中医药大学 | 一种基于血小板的免疫连接器的制备方法及应用 |
| CN116603073A (zh) * | 2023-05-29 | 2023-08-18 | 上海臻上医药科技有限公司 | 血小板负载的小分子药物制剂及其制备方法、和用途 |
| CN118806929B (zh) * | 2024-07-13 | 2026-02-06 | 江苏省肿瘤医院 | 一种复合型纳米硅球递药体系及其制备方法和应用 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB929401A (en) | 1958-12-22 | 1963-06-19 | Upjohn Co | Encapsulated emulsions and processes for their preparation |
| GB929406A (en) | 1958-12-22 | 1963-06-19 | Upjohn Co | A process for the production of encapsulated material |
| GB969808A (en) | 1962-06-08 | 1964-09-16 | Boots Pure Drug Co Ltd | Anthelmintic compositions and compounds |
| GB1413186A (en) | 1973-06-27 | 1975-11-12 | Toyo Jozo Kk | Process for encapsulation of medicaments |
| IT1148784B (it) | 1980-04-09 | 1986-12-03 | Eurand Spa | Procedimento per la preparazione di microcapsule in un veicolo liquido |
| US4794000A (en) | 1987-01-08 | 1988-12-27 | Synthetic Blood Corporation | Coacervate-based oral delivery system for medically useful compositions |
| US5019400A (en) | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
| US6197346B1 (en) | 1992-04-24 | 2001-03-06 | Brown Universtiy Research Foundation | Bioadhesive microspheres and their use as drug delivery and imaging systems |
| EP0804249A2 (en) | 1994-03-15 | 1997-11-05 | Brown University Research Foundation | Polymeric gene delivery system |
| JPH08109142A (ja) | 1994-08-16 | 1996-04-30 | S R L:Kk | 血小板薬物送達システム |
| US6143211A (en) | 1995-07-21 | 2000-11-07 | Brown University Foundation | Process for preparing microparticles through phase inversion phenomena |
| US7294455B2 (en) * | 2003-05-16 | 2007-11-13 | The University Of North Carolina At Chapel Hill | Fixed-dried platelets cross-linked to protein |
| US20060141482A1 (en) | 2004-12-23 | 2006-06-29 | Awdalla Essam T | Method and multicomponent conjugates for treating cancer |
| WO2006073446A2 (en) * | 2004-04-28 | 2006-07-13 | The Trustees Of The University Of Pennsylvania | Peptide-mediated protein transduction into cells the hematopoietic lineage |
| DK2439273T3 (da) | 2005-05-09 | 2019-06-03 | Ono Pharmaceutical Co | Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika |
| US20070178107A1 (en) * | 2006-01-31 | 2007-08-02 | Awdalla Essam T | Method and means for treating solid tumors |
| EP2018436A2 (en) | 2006-04-25 | 2009-01-28 | Immune Disease Institute Inc. | Targeted delivery to leukocytes using non-protein carriers |
| US8512697B2 (en) * | 2007-05-16 | 2013-08-20 | The University Of North Carolina At Chapel Hill | Delivery of micro- and nanoparticles with blood platelets |
| EP2111869A1 (en) | 2008-04-23 | 2009-10-28 | Stichting Sanquin Bloedvoorziening | Compositions and methods to enhance the immune system |
| WO2010014784A2 (en) | 2008-08-01 | 2010-02-04 | Bristol-Myers Squibb Company | Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases |
| EP3255060A1 (en) * | 2008-12-09 | 2017-12-13 | F. Hoffmann-La Roche AG | Anti-pd-l1 antibodies and their use to enhance t-cell function |
| US8673359B2 (en) | 2010-07-08 | 2014-03-18 | Brown University | Nanoparticle compositions and methods for improved oral delivery of active agents |
| HK1203971A1 (en) * | 2012-05-15 | 2015-11-06 | Bristol-Myers Squibb Company | Cancer immunotherapy by disrupting pd-1/pd-l1 signaling |
| WO2014120265A1 (en) * | 2013-02-02 | 2014-08-07 | Duke University | Method of isolating circulating tumor cells |
| JP6991857B2 (ja) | 2014-10-10 | 2022-01-13 | イデラ ファーマシューティカルズ インコーポレイテッド | Ｔｌｒ９アゴニストをチェックポイント阻害剤と共に用いるがんの治療 |
-
2017
- 2017-09-13 KR KR1020237022734A patent/KR20230109771A/ko not_active Ceased
- 2017-09-13 CN CN201780066511.5A patent/CN109890420B/zh not_active Expired - Fee Related
- 2017-09-13 CA CA3036693A patent/CA3036693A1/en active Pending
- 2017-09-13 AU AU2017327360A patent/AU2017327360A1/en not_active Abandoned
- 2017-09-13 JP JP2019513929A patent/JP7262774B2/ja active Active
- 2017-09-13 WO PCT/US2017/051376 patent/WO2018053010A1/en not_active Ceased
- 2017-09-13 US US16/332,939 patent/US11730765B2/en active Active
- 2017-09-13 KR KR1020197009451A patent/KR102557336B1/ko active Active
- 2017-09-13 EP EP17851460.0A patent/EP3512554B1/en active Active
-
2023
- 2023-04-05 JP JP2023061666A patent/JP7497087B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019530673A5 (enExample) | ||
| Bazeed et al. | Pancreatic cancer: challenges and opportunities in locoregional therapies | |
| Wang et al. | Janus gold triangle-mesoporous silica nanoplatforms for hypoxia-activated radio-chemo-photothermal therapy of liver cancer | |
| Duan et al. | Advances and prospects in the treatment of pancreatic cancer | |
| Wang et al. | Tumor-acidity and bioorthogonal chemistry-mediated on-site size transformation clustered nanosystem to overcome hypoxic resistance and enhance chemoimmunotherapy | |
| Wang et al. | Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine | |
| Jiang et al. | Metformin and docosahexaenoic acid hybrid micelles for premetastatic niche modulation and tumor metastasis suppression | |
| Jeong et al. | Development of highly efficient nanocarrier-mediated delivery approaches for cancer therapy | |
| Crous et al. | Photodynamic therapy of lung cancer, where are we? | |
| Miller et al. | Antiangiogenic antitumor activity of HPMA copolymer–paclitaxel–alendronate conjugate on breast cancer bone metastasis mouse model | |
| Dinakaran et al. | The use of nanomaterials in advancing photodynamic therapy (PDT) for deep-seated tumors and synergy with radiotherapy | |
| SG158919A1 (en) | Constructs binding to phosphatidylserine and their use in disease treatment | |
| Lopez et al. | Ultrasound therapy, chemotherapy and their combination for prostate cancer | |
| Baghban et al. | Were magnetic materials useful in cancer therapy? | |
| Singh et al. | The implications and future perspectives of nanomedicine for cancer stem cell targeted therapies | |
| Larsson et al. | Local co-administration of gene-silencing RNA and drugs in cancer therapy: State-of-the art and therapeutic potential | |
| Sawant et al. | Cancer research and therapy: Where are we today | |
| Cohen et al. | A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo | |
| Liu et al. | Advancing immune checkpoint blockade in colorectal cancer therapy with nanotechnology | |
| Timmer et al. | Locally advanced pancreatic cancer: percutaneous management using ablation, brachytherapy, intra-arterial chemotherapy, and intra-tumoral immunotherapy | |
| Maranhão et al. | Advances in non-invasive drug delivery for atherosclerotic heart disease | |
| Huang et al. | Irreversible electroporation-induced inflammation facilitates neutrophil-mediated drug delivery to enhance pancreatic cancer therapy | |
| Xu et al. | A photoactivatable self-assembled nanoagonist for synergistic therapy against pancreatic ductal adenocarcinoma | |
| Wang et al. | A low molecular weight multifunctional theranostic molecule for the treatment of prostate cancer | |
| Xu et al. | EUS-guided interventional therapies for pancreatic diseases |